NO20014891D0 - Fragmenter av virusprotein 2 eller 3 fra polyomavirus, anvendt for transportering av aktive ingredienser - Google Patents
Fragmenter av virusprotein 2 eller 3 fra polyomavirus, anvendt for transportering av aktive ingredienserInfo
- Publication number
- NO20014891D0 NO20014891D0 NO20014891A NO20014891A NO20014891D0 NO 20014891 D0 NO20014891 D0 NO 20014891D0 NO 20014891 A NO20014891 A NO 20014891A NO 20014891 A NO20014891 A NO 20014891A NO 20014891 D0 NO20014891 D0 NO 20014891D0
- Authority
- NO
- Norway
- Prior art keywords
- polyomavirus
- fragments
- active ingredients
- virus protein
- transporting active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/645—Secretins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Polyamides (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19916224A DE19916224C1 (de) | 1999-04-10 | 1999-04-10 | Synthetisches biologisch aktives Molekül |
PCT/DE2000/000976 WO2000061616A1 (de) | 1999-04-10 | 2000-04-03 | Fragmente des virus proteins 2 oder 3 des polymavirus als fähren für wirkstoffe |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20014891D0 true NO20014891D0 (no) | 2001-10-08 |
NO20014891L NO20014891L (no) | 2001-11-07 |
Family
ID=7904139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014891A NO20014891L (no) | 1999-04-10 | 2001-10-08 | Fragmenter av virusprotein 2 eller 3 fra polyomavirus, anvendt for transportering av aktive ingredienser |
Country Status (19)
Country | Link |
---|---|
US (2) | US7011968B1 (no) |
EP (2) | EP1173475B1 (no) |
JP (1) | JP2002544122A (no) |
KR (1) | KR100627935B1 (no) |
CN (1) | CN1346366A (no) |
AT (1) | ATE303401T1 (no) |
AU (1) | AU768669B2 (no) |
BR (1) | BR0011178A (no) |
CA (1) | CA2364536A1 (no) |
CZ (1) | CZ20013621A3 (no) |
DE (3) | DE19916224C1 (no) |
EA (1) | EA006631B1 (no) |
HU (1) | HUP0200679A2 (no) |
IL (1) | IL145403A0 (no) |
MX (1) | MXPA01010189A (no) |
NO (1) | NO20014891L (no) |
PL (1) | PL355852A1 (no) |
WO (1) | WO2000061616A1 (no) |
ZA (1) | ZA200107658B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19916224C1 (de) * | 1999-04-10 | 2000-06-21 | November Ag Molekulare Medizin | Synthetisches biologisch aktives Molekül |
GB2357084A (en) * | 1999-12-06 | 2001-06-13 | Amersham Pharm Biotech Uk Ltd | A hydrophobic carrier peptide |
DE10306789A1 (de) * | 2003-02-18 | 2004-08-26 | Responsif Gmbh | Zusammensetzung zur Verabreichung an ein Lebewesen und Verfahren zur Markierung von Mitteln |
US20090062237A1 (en) * | 2007-06-15 | 2009-03-05 | Mayo Foundation For Medical Education And Research | Evaluating immune competence |
EP2636746A1 (en) * | 2012-03-06 | 2013-09-11 | Life Science Inkubator | A novel drug delivery system based on JCV-VLP |
CN113278634B (zh) * | 2020-11-16 | 2022-06-28 | 艾棣维欣(苏州)生物制药有限公司 | 一种预防和治疗默克尔细胞癌的新型疫苗 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1319101C (en) | 1986-09-03 | 1993-06-15 | Marta Iris Sabara | Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
US4950599A (en) * | 1987-01-29 | 1990-08-21 | Wolf Bertling | Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments |
GB9114003D0 (en) | 1991-06-28 | 1991-08-14 | Mastico Robert A | Chimaeric protein |
DE656950T1 (de) * | 1992-08-21 | 1996-03-14 | Biogen Inc | Tat-derivate transport polypeptide. |
US5618536A (en) * | 1992-09-03 | 1997-04-08 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric papillomavirus-like particles |
DE4335025A1 (de) | 1993-10-14 | 1995-04-20 | Boehringer Ingelheim Int | Endosomolytisch wirksame Partikel |
DE19543553B4 (de) * | 1995-11-22 | 2009-04-09 | Deutsches Primatenzentrum Gmbh | VP-Antigene des JC-Virus |
DE19618797C2 (de) * | 1996-05-10 | 2000-03-23 | Bertling Wolf | Vehikel zum Transport molekularer Substanz |
US5858648A (en) * | 1996-11-04 | 1999-01-12 | Sienna Biotech, Inc. | Assays using reference microparticles |
DE19916224C1 (de) * | 1999-04-10 | 2000-06-21 | November Ag Molekulare Medizin | Synthetisches biologisch aktives Molekül |
-
1999
- 1999-04-10 DE DE19916224A patent/DE19916224C1/de not_active Expired - Fee Related
-
2000
- 2000-04-03 BR BR0011178-3A patent/BR0011178A/pt not_active Application Discontinuation
- 2000-04-03 DE DE10080849T patent/DE10080849D2/de not_active Expired - Fee Related
- 2000-04-03 EP EP00922458A patent/EP1173475B1/de not_active Expired - Lifetime
- 2000-04-03 AT AT00922458T patent/ATE303401T1/de not_active IP Right Cessation
- 2000-04-03 HU HU0200679A patent/HUP0200679A2/hu unknown
- 2000-04-03 DE DE50011068T patent/DE50011068D1/de not_active Expired - Fee Related
- 2000-04-03 EP EP05009073A patent/EP1586582A1/de not_active Withdrawn
- 2000-04-03 AU AU42850/00A patent/AU768669B2/en not_active Ceased
- 2000-04-03 EA EA200101066A patent/EA006631B1/ru not_active IP Right Cessation
- 2000-04-03 CA CA002364536A patent/CA2364536A1/en not_active Abandoned
- 2000-04-03 WO PCT/DE2000/000976 patent/WO2000061616A1/de active IP Right Grant
- 2000-04-03 PL PL00355852A patent/PL355852A1/xx not_active Application Discontinuation
- 2000-04-03 CZ CZ20013621A patent/CZ20013621A3/cs unknown
- 2000-04-03 IL IL14540300A patent/IL145403A0/xx unknown
- 2000-04-03 US US09/958,451 patent/US7011968B1/en not_active Expired - Fee Related
- 2000-04-03 JP JP2000611557A patent/JP2002544122A/ja active Pending
- 2000-04-03 KR KR1020017012890A patent/KR100627935B1/ko not_active IP Right Cessation
- 2000-04-03 MX MXPA01010189A patent/MXPA01010189A/es unknown
- 2000-04-03 CN CN00806109A patent/CN1346366A/zh active Pending
-
2001
- 2001-09-18 ZA ZA200107658A patent/ZA200107658B/en unknown
- 2001-10-08 NO NO20014891A patent/NO20014891L/no not_active Application Discontinuation
-
2005
- 2005-12-22 US US11/316,467 patent/US20070009921A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE303401T1 (de) | 2005-09-15 |
JP2002544122A (ja) | 2002-12-24 |
KR100627935B1 (ko) | 2006-09-22 |
PL355852A1 (en) | 2004-05-31 |
MXPA01010189A (es) | 2003-07-21 |
EP1173475A1 (de) | 2002-01-23 |
NO20014891L (no) | 2001-11-07 |
US7011968B1 (en) | 2006-03-14 |
EA200101066A1 (ru) | 2002-04-25 |
KR20020007361A (ko) | 2002-01-26 |
CA2364536A1 (en) | 2000-10-19 |
HUP0200679A2 (en) | 2002-06-29 |
ZA200107658B (en) | 2002-07-22 |
EP1586582A1 (de) | 2005-10-19 |
EA006631B1 (ru) | 2006-02-24 |
BR0011178A (pt) | 2002-05-21 |
CN1346366A (zh) | 2002-04-24 |
DE19916224C1 (de) | 2000-06-21 |
IL145403A0 (en) | 2002-06-30 |
EP1173475B1 (de) | 2005-08-31 |
DE50011068D1 (de) | 2005-10-06 |
US20070009921A1 (en) | 2007-01-11 |
DE10080849D2 (de) | 2002-06-27 |
CZ20013621A3 (cs) | 2002-05-15 |
WO2000061616A1 (de) | 2000-10-19 |
AU4285000A (en) | 2000-11-14 |
AU768669B2 (en) | 2003-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69713112D1 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin-analogen | |
DE59410380D1 (de) | Endosomolytisch wirksame partikel | |
CY1107051T1 (el) | Αντι-διηθητικα και αντι-αγγειογενετικα θραυσματα ουροκινασης και η χρηση τους | |
ES2121479T3 (es) | Solucion estabilizadora para proteinas y peptidos. | |
TR199802534T2 (xx) | Leptin (OB Protein) fragmanlar� | |
DK0848720T3 (da) | Antagonister af den onkogene aktivitet af proteinet Mdm2 og deres anvendelse ved behandling af cancere | |
PT1079849E (pt) | Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica | |
BR0012919A (pt) | Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv | |
DE69322872D1 (de) | Vakzine gegen immunodefizienz-virus der katze (kiv) | |
NO20014891D0 (no) | Fragmenter av virusprotein 2 eller 3 fra polyomavirus, anvendt for transportering av aktive ingredienser | |
DE69508382D1 (de) | Peptomere mit erhöhter immunogenizität | |
ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
DK1165102T3 (da) | Matrixproteinpræparater til podning i ikke-mineraliseret væv | |
KR940007059A (ko) | 변형된 혈소판 인자-4 | |
ES2122921B1 (es) | Proteinas recombinantes de fusion del virus reproductivo y respiratorio porcino (prrsv) y su empleo en diagnostico. | |
FR2766489B1 (fr) | Derives de streptogramines, leur preparation et les compositions qui les contiennent | |
DE69008701D1 (de) | Ein b-epitop des hüllglykoproteins eines retrovirus und ein t-epitop eines anderen proteins dieses retrovirus enthaltende zusammensetzung. | |
TR200002611T2 (tr) | Beta-lipotropin ve kullanımları | |
ATE346604T1 (de) | Verwendung von histonen zur herstellung von arzneimitteln | |
ATE282704T1 (de) | Isolierte und gereinigte humane lösliche guanylylcyclase alpha1/beta1 (hsgc alpha1/beta1) | |
RU94046405A (ru) | Птг-соединения и содержащий их фармацевтический состав, способ получения желаемых полипептидов, нуклеотидная последовательность, бактериальный вектор экспрессии, бактериальные хозяйские клетки и составной белок | |
RU99107378A (ru) | Применение белков в качестве антиретровирусных агентов | |
FR2792639B1 (fr) | Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |